These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25936315)

  • 1. Immunoadsorption with regenerating systems in neurological disorders --A single center experience.
    Hohenstein B; Passauer J; Ziemssen T; Julius U
    Atheroscler Suppl; 2015 May; 18():119-23. PubMed ID: 25936315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadsorption in neurological disorders.
    Oji S; Nomura K
    Transfus Apher Sci; 2017 Oct; 56(5):671-676. PubMed ID: 28919008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients.
    Heigl F; Hettich R; Arendt R; Durner J; Koehler J; Mauch E
    Atheroscler Suppl; 2013 Jan; 14(1):167-73. PubMed ID: 23357160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
    Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
    Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
    Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital Dresden.
    Dittrich-Riediger J; Schatz U; Hohenstein B; Julius U
    Atheroscler Suppl; 2015 May; 18():45-52. PubMed ID: 25936304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies--perspectives for immunoadsorption.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2013 Jan; 14(1):161-5. PubMed ID: 23357159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide based adsorbers for therapeutic immunoadsorption.
    Rönspeck W; Brinckmann R; Egner R; Gebauer F; Winkler D; Jekow P; Wallukat G; Müller J; Kunze R
    Ther Apher Dial; 2003 Feb; 7(1):91-7. PubMed ID: 12921122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadsorption for autoimmune encephalitis.
    Fassbender C; Klingel R; Köhler W
    Atheroscler Suppl; 2017 Nov; 30():257-263. PubMed ID: 29096847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic plasma exchange for neuroimmunological disorders].
    Shibuya N
    No To Shinkei; 1993 Oct; 45(10):925-32. PubMed ID: 8268032
    [No Abstract]   [Full Text] [Related]  

  • 11. Apheresis in treatment of acute inflammatory demyelinating disorders.
    Mühlhausen J; Kitze B; Huppke P; Müller GA; Koziolek MJ
    Atheroscler Suppl; 2015 May; 18():251-6. PubMed ID: 25936333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
    Loschiavo C; Grecò M; Polo A; Del Colle R
    G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications.
    Fuchs K; Rummler S; Ries W; Helmschrott M; Selbach J; Ernst F; Morath C; Gauly A; Atiye S; Stauss-Grabo M; Giefer M
    Ther Apher Dial; 2022 Feb; 26(1):229-241. PubMed ID: 33914397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoadsorption for connective tissue disease.
    Hohenstein B; Bornstein SR; Aringer M
    Atheroscler Suppl; 2013 Jan; 14(1):185-9. PubMed ID: 23357163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two.
    Zöllner S; Pablik E; Druml W; Derfler K; Rees A; Biesenbach P
    Blood Purif; 2014; 38(2):160-6. PubMed ID: 25501972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange and immunoadsorption for autoimmune neurologic diseases - current guidelines and future perspectives.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2009 Dec; 10(5):129-32. PubMed ID: 20129391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New trends in specific immunoadsorption.
    Ullrich H; Kuehnl P
    Transfus Apher Sci; 2004 Jun; 30(3):223-31. PubMed ID: 15172628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathy.
    Lieker I; Slowinski T; Harms L; Hahn K; Klehmet J
    J Clin Apher; 2017 Dec; 32(6):486-493. PubMed ID: 28485075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal antibody elimination in neuroimmunological diseases.
    Toepfer M; Schiffl H; Sitter T; Pongratz D; Müller-Felber W
    Ther Apher; 1999 Aug; 3(3):268-70. PubMed ID: 10427627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoadsorption in steroid-refractory multiple sclerosis.
    Koziolek MJ; Kitze B; Mühlhausen J; Müller GA
    Atheroscler Suppl; 2013 Jan; 14(1):175-8. PubMed ID: 23357161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.